Cuccia V, Rodriguez F, Palma F, Zuccaro G (2006) Pinealoblastomas in children. Childs Nerv Syst 22:577–585. https://doi.org/10.1007/s00381-006-0095-6
Palled S, Kalavagunta S, Beerappa Gowda J et al (2014) Tackling a recurrent pinealoblastoma. Case Rep Oncol Med 2014:135435. https://doi.org/10.1155/2014/135435
Article PubMed PubMed Central Google Scholar
Nozza P, Casciana ML, Rossi A et al (2010) Post-chemotherapy maturation of a pineoblastoma. Acta Neuropathol 119:651–653. https://doi.org/10.1007/s00401-010-0668-z
Mynarek M, Pizer B, Dufour C et al (2017) Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data. Neuro Oncol 19:576–585. https://doi.org/10.1093/neuonc/now234
Article CAS PubMed PubMed Central Google Scholar
Ai P, Peng X, Jiang Y et al (2015) Complete regression of adult pineoblastoma following radiotherapy: A case report and review of the literature. Oncol Lett 10:2329–2332. https://doi.org/10.3892/ol.2015.3574
Article PubMed PubMed Central Google Scholar
Gaito S, Malagoli M, Depenni R et al (2019) Pineoblastoma in Adults: A Rare Case Successfully Treated with Multimodal Approach Including Craniospinal Irradiation Using Helical Tomotherapy. Cureus 11:e5852. https://doi.org/10.7759/cureus.5852
Article PubMed PubMed Central Google Scholar
Tate M, Sughrue ME, Rutkowski MJ et al (2012) The long-term postsurgical prognosis of patients with pineoblastoma. Cancer 118:173–179. https://doi.org/10.1002/cncr.26300
Liu APY, Li BK, Vasiljevic A et al (2024) SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors. Neuro Oncol 26:2159–2173. https://doi.org/10.1093/neuonc/noae128
Article CAS PubMed PubMed Central Google Scholar
Greppin K, Cioffi G, Waite KA et al (2022) Epidemiology of pineoblastoma in the United States, 2000–2017. Neurooncol Pract 9:149–157. https://doi.org/10.1093/nop/npac009
Article PubMed PubMed Central Google Scholar
Huo XL, Wang B, Zhang GJ et al (2020) Adverse Factors of Treatment Response and Overall Survival in Pediatric and Adult Patients with Pineoblastoma. Cancer Manag Res 12:7343–7351. https://doi.org/10.2147/CMAR.S258476
Article PubMed PubMed Central Google Scholar
Gener MA, Conger AR, Van Gompel J et al (2015) Clinical, Pathological, and Surgical Outcomes for Adult Pineoblastomas. World Neurosurg 84:1816–1824. https://doi.org/10.1016/j.wneu.2015.08.005
Chang SM, Lillis-Hearne PK, Larson DA et al (1995) Pineoblastoma in adults. Neurosurgery 37:383–390 discussion 390 – 381. https://doi.org/10.1227/00006123-199509000-00003
Article CAS PubMed Google Scholar
Barlas O, Bayindir C, Imer M et al (2000) Non-resective management of pineoblastoma. Minim Invasive Neurosurg 43:163–170. https://doi.org/10.1055/s-2000-14509
Article CAS PubMed Google Scholar
Stoiber EM, Schaible B, Herfarth K et al (2010) Long term outcome of adolescent and adult patients with pineal parenchymal tumors treated with fractionated radiotherapy between 1982 and 2003–a single institution’s experience. Radiat Oncol 5:122. https://doi.org/10.1186/1748-717X-5-122
Article PubMed PubMed Central Google Scholar
Liu APY, Li BK, Pfaff E et al (2021) Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study. Acta Neuropathol 141:771–785. https://doi.org/10.1007/s00401-021-02284-5
Article CAS PubMed PubMed Central Google Scholar
Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1
Nakashima T, Yamamoto R, Ohno M et al (2024) Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for gliomas. Brain Tumor Pathol 41:50–60. https://doi.org/10.1007/s10014-023-00476-3
Article CAS PubMed Google Scholar
Lee JY, Wakabayashi T, Yoshida J (2005) Management and survival of pineoblastoma: an analysis of 34 adults from the brain tumor registry of Japan. Neurol Med Chir (Tokyo) 45:132–141 discussion 141 – 132. https://doi.org/10.2176/nmc.45.132
Elhemaly A, Zaghloul MS, Ahmed S et al (2021) Prognostic factors and outcome of pineoblastoma: 10 years single-center experience. J Egypt Natl Canc Inst 33:26. https://doi.org/10.1186/s43046-021-00083-3
Hinkes BG, von Hoff K, Deinlein F et al (2007) Childhood pineoblastoma: experiences from the prospective multicenter trials HIT-SKK87, HIT-SKK92 and HIT91. J Neurooncol 81:217–223. https://doi.org/10.1007/s11060-006-9221-2
Article CAS PubMed Google Scholar
Mehkri Y, Gendreau JL, Fox K et al (2023) Radiotherapy Is Associated With Improved Overall Survival in Adult Pineoblastoma: A SEER Database Analysis. World Neurosurg 172:e312–e318. https://doi.org/10.1016/j.wneu.2023.01.014
Nandoliya KR, Sadagopan NS, Thirunavu V et al (2023) Post-Surgical Prognosis of Patients with Pineoblastoma: A Systematic Review and Individual Patient Data Analysis with Trends over Time. Cancers (Basel) 15. https://doi.org/10.3390/cancers15133374
Horiba A, Hayashi M, Tamura N et al (2018) Gamma Knife treatment of malignant infantile brain tumors - Case report. J Radiosurg SBRT 5:249–253
PubMed PubMed Central Google Scholar
Yonezawa H, Ohno M, Igaki H et al (2021) Outcomes of salvage fractionated re-irradiation combined with bevacizumab for recurrent high-grade gliomas that progressed after bevacizumab treatment*. Jpn J Clin Oncol 51:1028–1035. https://doi.org/10.1093/jjco/hyab063
Cuneo KC, Vredenburgh JJ, Sampson JH et al (2012) Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 82:2018–2024. https://doi.org/10.1016/j.ijrobp.2010.12.074
Article CAS PubMed Google Scholar
Chamberlain MC, Eaton KD, Fink J (2011) Radiation-induced myelopathy: treatment with bevacizumab. Arch Neurol 68:1608–1609. https://doi.org/10.1001/archneurol.2011.621
Shah N, Ranjan S (2022) Successful treatment of quadriparesis from radiation myelopathy with bevacizumab in a patient with metastatic breast cancer. BMJ case Rep 15:e246470. https://doi.org/10.1136/bcr-2021-246470
Article PubMed PubMed Central Google Scholar
Psimaras D, Tafani C, Ducray F (2016) Bevacizumab in late-onset radiation-induced myelopathy. Neurology 86:454–457. https://doi.org/10.1212/WNL.0000000000002345
Article CAS PubMed Google Scholar
Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106
Article CAS PubMed PubMed Central Google Scholar
Li BK, Vasiljevic A, Dufour C et al (2020) Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study. Acta Neuropathol 139:223–241. https://doi.org/10.1007/s00401-019-02111-y
Comments (0)